Triple agonist of the GIP · GLP-1 · glucagon receptors
Triple GIP/GLP-1/glucagon agonist for advanced metabolic research. HPLC purity ≥ 99%. For laboratory research use only.
or check out instantly
For laboratory research use only. Not for human or animal consumption.
Retatrutide (research designation LY3437943) is a synthetic peptide that acts simultaneously on three metabolic receptors: GIP, GLP-1 and the glucagon receptor. This triple action makes it one of the most studied compounds in current research on glucose homeostasis, energy expenditure and body-weight regulation. Each vial ships as a lyophilized powder, third-party tested and accompanied by its certificate of analysis.
| Research name | Retatrutide (LY3437943) |
| CAS number | 2381089-83-2 |
| Targets | GIP · GLP-1 · glucagon receptor |
| Presentation | Lyophilized powder |
| Purity (HPLC) | ≥ 99% |
| Available formats | 10 mg · 20 mg |
| Storage | -20 °C, protected from light |
| Solubility | Bacteriostatic water / sterile water |
Reconstitute the lyophilized powder by dispensing bacteriostatic water slowly down the inner wall of the vial; do not shake. Allow dissolution to complete fully before preparing samples for in vitro analysis. Divide into single-use aliquots to avoid freeze–thaw cycles, document the lot number and preparation date, and store at 2–8 °C.
CJC-1295 + Ipamorelin blend studied for GH secretion. HPLC purity ≥ 99%. For laboratory research use only.
Researcher verification
PurePeptide supplies research compounds strictly for in-vitro laboratory / research use — not for human or veterinary consumption. By entering you confirm you are at least 21 and agree to our terms & conditions.